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Abstract
Salmonella Typhimurium is a major cause of human gastroenteritis. The Salmonella type III secretory system secretes
virulence proteins, called effectors. Effectors are responsible for the alteration of tight junction (TJ) structure and function in
intestinal epithelial cells. AvrA is a newly described bacterial effector found in Salmonella. We report here that AvrA
expression stabilizes cell permeability and tight junctions in intestinal epithelial cells. Cells colonized with an AvrA-deficient
bacterial strain (AvrA2) displayed decreased cell permeability, disruption of TJs, and an increased inflammatory response.
Western blot data showed that TJ proteins, such as ZO-1, claudin-1, decreased after AvrA- colonization for only 1 hour. In
contrast, cells colonized with AvrA-sufficient bacteria maintained cell permeability with stabilized TJ structure. This
difference was confirmed in vivo. Fluorescent tracer studies showed increased fluorescence in the blood of mice infected
with AvrA- compared to those infected with the AvrA-sufficient strains. AvrA- disrupted TJ structure and function and
increased inflammation in vivo, compared to the AvrA- sufficient strain. Additionally, AvrA overexpression increased TJ
protein expression when transfected into colonic epithelial cells. An intriguing aspect of this study is that AvrA stabilized TJs,
even though the other TTSS proteins, SopB, SopE, and SopE2, are known to disrupt TJs. AvrA may play a role in stabilizing
TJs and balancing the opposing action of other bacterial effectors. Our findings indicate an important role for the bacterial
effector AvrA in regulation of intestinal epithelial cell TJs during inflammation. The role of AvrA represents a highly refined
bacterial strategy that helps the bacteria survive in the host and dampen the inflammatory response.
Citation: Liao AP, Petrof EO, Kuppireddi S, Zhao Y, Xia Y, et al (2008) Salmonella Type III Effector AvrA Stabilizes Cell Tight Junctions to Inhibit Inflammation in
Intestinal Epithelial Cells. PLoS ONE 3(6): e2369. doi:10.1371/journal.pone.0002369
Editor: Niyaz Ahmed, Centre for DNA Fingerprinting and Diagnostics, India
Received January 15, 2008; Accepted April 25, 2008; Published June 4, 2008
Copyright:  2008 Liao et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by NIDDK KO1 DK075386 to J. S. The funder played no role in the design and conduct of the study, in the collection, analysis,
and interpretation of the data, and in the preparation, review, or approval of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jun_sun@umrc.rochester.edu
Introduction
Intestinal epithelial cells participate in immune regulation and
mucosal integrity. Tight junctions (TJs) constitute continuous
circumferential seals around cells and serve as a protective barrier,
preventing solutes and water from passing freely through the
paracellular pathway. Tight junctions can be altered by various
pathogens, as well as by their toxins. These effects may result from
direct modification of TJ proteins such as occludin, claudin, and
ZO-1, or by alteration of the perijunctional actomyosin ring
[1,2,3].
Salmonella enterica serovar Typhimurium is a major cause of
human gastroenteritis. Infection of polarized epithelial cell
monolayers by S. Typhimurium disrupts TJ structure and function
[4,5,6,7]. TJ disruption is dependent on the type III secretory
system (TTSS) of Salmonella. TTSS is a needle-like protein
transport device used by Gram-negative pathogenic bacteria. It
allows bacteria to inject virulence effectors into eukaryotic host
cells [8]. TTSS is encoded by the Salmonella pathogenicity island 1
(SPI-1) [9]. A recent study indicated that SopB, SopE, SopE2, and
SpiA are the TTSS secreted SPI-1 effectors responsible for the
disruption of TJ structure and function [10]. The specific bacterial
effectors responsible for the regulation of TJs, however, remains to
be identified. The majority of published studies regarding
Salmonella and TJ have utilized in vitro cultured epithelial models.
The physiological consequences of Salmonella-effector-induced
alteration of TJ function need to be addressed in vivo using animal
models.
AvrA is a newly described bacterial effector transported into the
host cell by the TTSS of Salmonella [11]. It also belongs to the SPI-
1 [11]. The SPI-1 effectors are responsible for early inflammation
in the mouse model of S. Typhimurium-induced enterocolitis
[12,13]. AvrA protein from Salmonella Typhimurium inhibits
activation of the proinflammatory NF-kB transcription factor in
cultured human epithelial cells [14]. Based on the sequence
alignment, AvrA belongs to the cysteine protease family [15].
Representative AvrA members include the adenovirus-like prote-
ases (human adenovirus type 2, fowl adenovirus 8, Hemorrhagic
enteritis virus), YopJ (Yersinia outer protein J), and AvrBsT. The
catalytic triad for the cysteine protease is present in all AvrA family
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a mutant AvrA protein with a single amino acid residue transition
(AvrA/C186A) in a putative catalytic cysteine of this enzyme did
not inhibit TNFa-stimulated induction of the reporter [14]. We
recently demonstrate that AvrA has deubiquitinase activity which
removes ubiquitins from ub-IkBa, thus inhibiting NF-kB activity
[17]. AvrA C186A mutant protein had reduced deubiquitinase
activity as evidenced by cleaving less ubiquitin moieties from IkBa
[17]. This data further supports the hypothesis that AvrA protein
has protease activity which attenuates the proinflammatory NF-kB
pathway.
The AvrA gene is present in 80% of Salmonella enterica serovars
[18]. The protein expression of AvrA differs strikingly between
bacterial strains in systemic disease and in enteritis which is
localized to the intestine [18]. AvrA protein was not expressed in
strains related to systemic disease, but was conditionally (pH below
6.0) expressed in the enteritis-related strains. In addition, S. enterica
strains from systemic infections could be characterized by their
strong SopB and SopE1 expression and by the absence of SopD1
and AvrA proteins [18]. Ben-Barak et al. [19] identified four
phenotypic classes of S. enterica under defined standard culture
conditions: strains with a constitutive synthesis of AvrA; strains
with an acid induction of AvrA; strains with silent avrA genes; and
a fourth class without AvrA gene [19]. Taken together, AvrA
protein expression is very different from the other Salmonella
effectors such as SopB, SopD, and SopE [19]. Although it is
premature to claim a correlation of AvrA with the clinical and
epidemiological potency of Salmonellae, current studies indicate that
a fine-tuning of AvrA expression takes place during the
pathogenesis of Salmonella infection.
Unlike SopB and SopD, AvrA does not increase physiologic
fluid secretion into infected calf ileal loops [20],[21]. However, the
role of AvrA expression on the tight junction structure and
function of the intestinal epithelial cells in both in vitro and in vivo
models is unexplored. To determine if AvrA was responsible for
the TJ protein expression and distribution, we focused on bacterial
strains sufficient or deficient in AvrA—parental PhoP
c, PhoP
c
AvrA mutant (AvrA2) or the AvrA complementary strain (PhoP
c
AvrA2/AvrA+). PhoP
c is a PhoP-PhoQ constitutive mutation of a
WT Salmonella Typhimurium strain 14028s that increases the
expression of PhoP-activated genes, represses the synthesis of
approximately 20 proteins encoded by the PhoP-repressed genes,
and attenuates virulence [22]. Reed et al., showed that PhoP
c has
similar adherence ability as the WT Salmonella and is less invasive
than the WT Salmonella using the MDCK and T84 cell models
[23]. A previous study demonstrated that PhoP
c is able to inhibit
the activation of the proinflammatory NF-kB pathway [24].
Further study showed that AvrA expression in PhoP
c plays an
importance role in attenuating the NF-kB activity by stabilizing
IkBa, the inhibitor of NF-kB [14] [17]. In current study, we
continue to use this Salmonella-epithelial interaction system.
We hypothesized that AvrA expression in Salmonella Typhimur-
ium is able to regulate the TJ protein expression and distribution
in intestinal epithelial cells, and hence, change TJ structure. We
have tested Salmonella Typhimurium with AvrA sufficient or
deficient expression in a cultured polarized human epithelial cell
model, an animal model, and in AvrA-transfected cells. We
demonstrate that Salmonella lacking AvrA decreased tight junction
protein expression in both cultured colonic epithelial cell and
bacterial infected mouse models. While examining changes in
resistance and cell permeability, we also investigated TJ protein
expression, as well as effects on TJ protein distribution induced by
AvrA-deficient and -sufficient bacterial strains in vitro and in vivo.
Our data demonstrate that TJ protein expression increased
significantly in cells transiently transfected with the AvrA gene.
Our findings suggest an important role for the bacterial effector
AvrA in regulating the structure and function of tight junctions in
intestinal epithelial cells.
Materials and Methods
Cell culture
T84 epithelial cells (American Type Culture Collection,
Manassas, VA) were grown in 1:1 DMEM and Ham’s F-12
medium supplemented with 15 mM HEPES (pH 7.5), 14 mM
NaHCO3, antibiotics, and 5% neonatal calf serum. HT29-CL19A
cells were grown in DMEM (high glucose, 4.5 g/L) containing 5%
(vol/vol) fetal bovine serum, 50 ug/ml streptomycin, and 50 U/ml
penicillin. Monolayers of T84 and HT29-CL19A cells were grown
on permeable supports (0.33 or 4.67 cm
2, 0.4 mm pore. Costar,
Cambridge, MA) and utilized 6–14 days (T84) or 4–6 days (HT-
29-CL19A) after being plated.
Bacterial strains and growth conditions
Bacteria strains included wild-type (WT) S. Typhimurium
ATCC 14028s; S. Typhimurium PhoP
c, a derivative of wild-type
Salmonella SL14028 [22] with AvrA gene and protein expression;
Salmonella PhoP
c mutant strain lacking the AvrA gene (PhoP
c
AvrA2); PhoP
c AvrA- transcomplemented with a plasmid
encoding WT AvrA (PhoP
c AvrA2/AvrA+) [14]; and Escherichia
coli F18 (a flagellated nonpathogenic strain [25,26]). S. typhimurium
mutant PhoP
c, PhoP
c AvrA-, and PhoP
c AvrA2/AvrA+ were
provided by Dr. Andrew Neish of Emory University. The wild-
type strain Salmonella ATCC 14028s used in our study is known to
have the AvrA gene but has low AvrA protein expression [18,19].
Wild-type S. typhimurium AvrA+ was generated by transforming
with the pWSK29-AvrA plasmid and ampcillin-resistance selected.
Bacterial growth conditions were as follows: non-agitated micro-
aerophilic bacterial cultures were prepared by inoculation of 10 ml
of Luria-Bertani broth with 0.01 ml of a stationary phase culture,
followed by overnight incubation (,18 h) at 37uC, as previously
described [25]. Bacterial overnight cultures were concentrated 33-
fold in Hank’s balanced salt solution (HBSS) supplemented with
10 mM HEPES, pH 7.4.
Bacterial colonization in the polarized epithelial cells in
vitro
Polarized human colonic epithelial cells were colonized with
equal numbers of the indicated bacteria for 30 min, washed with
HBSS, and incubated in DMEM containing gentamicin (500 mg/
ml) for the times indicated in our previous study [17,27]. The first
30-minute incubation allowed bacteria to contact the surface of
the epithelial cells and inject the effectors in the host cells. After
extensive HBSS washing, the extracellular bacteria were washed
away. Incubation with gentamicin inhibited the growth of
bacteria. In this way, we focused on the effects of the bacterial
effectors injected to the host cells.
Streptomycin pre-treated mouse model
Animal experiments were performed using specific-pathogen-
free female C57BL/6 mice (Taconic) that were 6–7 weeks old.
The protocol was approved by the University of Rochester
Committee on Animal Recources Water and food were withdrawn
4 h before oral gavage with 7.5 mg/mouse of streptomycin (75 ml
of sterile solution or 75 ml of sterile water [control]). Afterwards,
animals were supplied with water and food ad libitum. Twenty
hours after streptomycin treatment, water and food were
AvrA Tight Junction
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1610
7 CFU of S. typhimurium (50-ml suspension in HBSS) or treated
with sterile HBSS (control) by oral gavage as previously described
[25]. At 6, 18, and 24 hours after infection, mice were sacrificed
and tissue samples from the intestinal tracts were removed for
analysis.
Immunoblotting
Mouse epithelial cells were scraped and lysed in lysis buffer (1%
Triton X-100, 150 mM NaCl, 10 mM Tris pH 7.4, 1 mM EDTA,
1 mM EGTA pH 8.0, 0.2 mM sodium ortho-vanadate, protease
inhibitor cocktail) and protein concentration measured. T84 or
HT29-CL19A Cells were colonized with equal numbers of the
indicated bacteria for 30 minutes, washed with HBSS, and incubated
in DMEM containing gentamicin (500 mg/ml) for the times
indicated. Cells were lysed in protein loading buffer (50 mM Tris,
pH 6.8, 100 mM dithiothreitol, 2% SDS, 0.1% bromphenol blue,
10% glycerol). Equal volumes of total cell lysate were separated by
SDS-PAGE, transferred to nitrocellulose, and processed for immu-
noblotting with Mouse anti-a-catenin, Rabbit anti-claudin-1, Mouse
anti-occludin-1, Mouse anti-ZO-1 antibodies from Zymed Labora-
tories Inc.(South San Francisco, CA), or E-cadherin antibodies from
BD Transduction Laboratories( Franklin Lakes, NJ).
Immunoblotting for AvrA
Bacteria were lysed in lysis buffer [in mM: 50 Tris, pH 8.0, 150
NaCl, 5 EDTA with a complete Mini protease inhibitor cocktail (1
tablet/10 ml, Roche), and 1% Triton X-100], and sonicated.
Equal amounts of total proteins were loaded, separated by SDS-
PAGE, and processed for immunoblotting with custom-made
AvrA antibody. The 15 amino acid (aa) peptide CGEEPFLPSD-
KADRY was designed based on the AvrA sequence aa#216-230
(GenBank accession no. AE008830).
AvrA transfection
HT29CL19A cells were grown in 12-well plates. At 70–80%
confluence, cells were transfected with a pCMV-myc-AvrA wild-
type gene construct, a pCMV-myc-AvrAC186A AvrA mutant
construct, or control empty pCMV-myc plasmid using LipofectA-
MINE (Invitrogen). The AvrA mutant C186A is a single amino
acid residue transition which is mutated at the key cysteine
required for AvrA’s activity as previously described [14,17]. 24 h
after transfection, cells were lysed in protein loading buffer
(50 mM Tris, pH 6.8, 100 mM dithiothreitol, 2% SDS, 0.1%
bromophenol blue, 10% glycerol). Equal volumes of total cell
lysate were separated by SDS-PAGE, transferred to nitrocellulose,
and processed for immunoblotting.
Immunofluorescence staining
Cultured epithelial cells T84 or HT29-CL19A were incubated
with equal numbers of the indicated bacteria for 30 minutes and
washed with HBSS. Immunofluorescent labeling of cells grown on
inserts was performed as follows: cells were fixed for 30 minutes in
1% paraformaldehyde in PBS and then washed in PBS. Fixed
samples were incubated in blocking solution (5% bovine serum
albumin, 0.1% saponin, 1 mM calcium in PBS) for 20 minutes,
followed by a 90 minute incubation with primary antibodies diluted
in blocking solution (1% bovine serum albumin, 0.1% saponin,
1 mM calcium in PBS): 1:100 Rabbit anti-Claudin-1 (Zymed
Laboratories Inc., South San Francisco, CA); 1:1000 Mouse anti-
ZO-1 (Zymed Laboratories Inc., San Francisco, CA). After a
60 minute incubation with secondary antibodies: 1:200 Alexa Fluor
488 goat-anti-rabbit IgG H+L; 1:200 Alexa Fluor 594 goat-anti-
mouse IgG H+L; 1:10,000 49,6-diamidino-2-phenyl-indole, dihy-
drochoride (DAPI) (all from Molecular Probes, Eugene, OR), the
inserts were mounted with SlowFade (SlowFadeH AntiFade Kit,
Molecular Probes) followed by a coverslip, and the edges were
sealed to prevent drying. Specimens were examined with a Leica
SP2 A OBS Laser Scanning confocal microscope.
Colonic tissues from the proximal and distal portion of the colon
were freshly isolated and embedded in paraffin wax after fixation
with 10% neutral buffered formalin. After preparation of the slides
as described above, slides were incubated in 3% H2O2 for
20 minutes at room temperature to block endogenous peroxidase
activity, followed by incubation for 20 min in 5% BSA with 0.1%
saponin in PBS to reduce nonspecific background. The samples
were incubated with primary antibodies as indicated for 90 minutes
at room temperature. Samples were then incubated with goat anti-
rabbit Alexa Fluor 488 (Molecular Probes, Invitrogen Detection
Technologies, Eugene, OR, USA; 1:200), goat anti-mouse Alexa
Fluor 594 (Molecular Probes, CA, USA; 1:200), and DAPI
(Molecular Probes 1:10 000) for 1 h at room temperature. Tissues
were mounted with SlowFade. Specimens were examined with a
Leica SP2 A OBS Laser Scanning confocal microscope.
TER measurement
Cells were grown as monolayers on collagen-coated polycar-
bonate membrane Transwell supports (Corning-Costar, Acton,
MA). Cells were colonized with equal numbers of the indicated
bacteria for 30 minutes, washed with HBSS, and incubated in
DMEM containing gentamicin (500 mg/ml, Invitrogen Corpora-
tion) for the time indicated. Transepithelial resistance (TER) was
measured with an epithelial voltohmmeter (EVOM, World
Precision Instruments, Sarasota, FL). Each measurement was
performed in triplicate.
Fluorescence Permeability in vivo
Streptomycin pre-treated mice were infected with different
bacterial strains for 24 hours. Fluorescein Dextran (Molecular
weight 3000 Da, diluted in HBSS) was gavaged (50 mg/g mouse).
Four hours later, mouse blood samples were collected by cardiac
puncture. Fluorescence intensity of the plasma was measured on a
fluorescent plate reader [28].
Statistical Analysis
Data are expressed as mean6SD. Differences between two
samples were analyzed by Student’s t test. P-values of 0.05 or less
were considered significant.
Results
AvrA expression alters tight junction protein expression
in human epithelial cells
First, we analyzed whether infection of T84 cell monolayers
with AvrA protein-sufficient or -deficient bacterial strains could
influence the expression of the major proteins which comprise the
tight junction complex. We assessed the expression of the tight
junction proteins, claudin-1, occludin-1, and Zonula occludens-1
(ZO-1) by Western blot. We also tested the adhesion protein E-
cadherin. After bacterial colonization in epithelial cells for only
one hour, both the wild-type S. Typhimurium 14028s (with
insufficient AvrA expression) and the PhoP
c AvrA mutant strain
lacking the AvrA gene (PhoP
c AvrA2) led to a down-regulation of
the TJ proteins ZO-1, occludin, and claudin-1 ( Fig. 1A). In
contrast, the parental PhoP
c with sufficient AvrA expression
stabilized TJ protein expression. E.coli F18 failed to modulate the
expression of occludin-1 and claudin-1, which is consistent with
AvrA Tight Junction
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intensity analysis demonstrated that occludin and ZO-1 expression
was significantly increased by the presence of PhoP
c with AvrA
protein expression, whereas the AvrA-deficient strain (AvrA2) and
wild-type Salmonella 14028s with insufficient AvrA protein induced
a significantly less in ZO-1 and occludin expression. AvrA
expression also stabilized TJ proteins in HT-29CL19A monolayers
(data not shown).
AvrA overexpression in epithelial cells increases TJ
protein expression
To determine whether AvrA expression directly regulates TJ
protein, we transfected human colonic epithelial HT29CL19A
cells with a pCMV-myc-AvrA wild-type gene construct, a pCMV-
myc-AvrAC186A AvrA mutant construct, or a control pCMV-myc
plasmid. The AvrA mutant C186A is a single amino acid residue
transition which is mutated at the key cysteine required for AvrA
activity as previously described [14,17]. As shown in Fig. 2, AvrA
overexpression in colonic epithelial cells increased ZO-1, claudin-
1, and occludin-1 expression significantly, whereas the AvrA
mutant C186A was able to reverse the effect and decrease the TJ
protein expression to the levels comparable to those in the cells
transfected with empty pCMV-myc vector. These data indicate
that AvrA expression directly increases TJ protein expression. The
cysteine site required for the AvrA activity is involved in AvrA
regulation of TJ protein expression.
AvrA expression alters tight junction protein distribution
in vitro
We further examined tight junction protein distribution.
Epithelial cells colonized with AvrA-sufficient or -deficient strains
were analyzed for the location of claudin-1 and ZO-1.
ZO-1: ZO-1 is a cytoplasmic plaque tight junction protein. In
control monolayers without any treatment, ZO-1 was restricted to
cellular borders and distributed in a smooth arc-like pattern. In
Figure 1. AvrA expression stabilizes the protein expressions of
occludin and ZO-1 in vitro. (A) Western blot of occludin-1, ZO-1,
claudin-1, and E-cadherin. Polarized human colonic epithelial T84 cells
were colonized with AvrA-deficient or -sufficient bacterial strains for
30 minutes, washed with HBSS and incubated in DMEM for 30 minutes.
Cells were lysed. Equal volumes of total cell lysate were processed for
immunoblotting with Rabbit anti-claudin-1, Mouse anti-occludin-1,
Mouse anti-ZO-1 antibodies, or E-cadherin antibodies. Experimental
groups: Control: polarized T84 cells without any treatment; WT: wild-
type S. Typhimurium ATCC 14028s without sufficient AvrA protein
expression; PhoP
c:p a r e n t a lP h o P
c with sufficient AvrA protein
expression; AvrA
2: PhoP
c AvrA mutant; AvrA
2/AvrA
+: PhoP
c AvrA-
transcomplemented with a plasmid encoding WT AvrA; or E.coli F18:
commensal bacteria isolated from human intestine. (B) Densitometry of
occludin and ZO-1. Relative occludin-1 and ZO-1 band intensity was
determined using NIH Image 1.63 software. Occludin-1 and ZO-1
expression significantly increased in the PhoP
c group compared to the
Control, WT, and AvrA- groups in absence of AvrA protein. * P,0.05.
Data are reported as mean6SD of 3 independent experiments.
doi:10.1371/journal.pone.0002369.g001
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Figure 2. AvrA transfection in epithelial cells increases TJ
protein expression. (A) HT29C19A cells were transfected with a
pCMV-myc-AvrA wild-type gene construct, a pCMV-myc-AvrAC186A
AvrA mutant construct, or control empty pCMV-myc plasmid using
LipofectAMINE (Invitrogen). The AvrA mutant C186A is a single amino
acid residue transition which is mutated at the key cysteine required for
AvrA activity. 24 h after transfection, cells were lysed in protein-loading
buffer. Equal volumes of total cell lysis were processed for immuno-
blotting for ZO-1, occludin-1, claudin-1, AvrA, and b-actin. Control:
normal HT29Cl19A without treatment; pCMV: cells transfected with
empty pCMV-myc plasmid; AvrA: cells transfected with pCMV-myc-AvrA
plasmid; C186A: cells transfected with AvrA mutant C186A plasmid. (B)
Densitometry of ZO-1, occludin-1, and claudin-1. These are significant
increase of ZO-1 and occludin-1 expression in AvrA-overexpressed cells
compared to the cells without AvrA expression. AvrA mutant C186A
expression did not increase ZO-1 and occludin-1 expression. It indicates
that cysteine mutation abolished the effects of wild-type AvrA on TJ
protein expression. * P,0.05, ** P,0.01. Data are reported as
mean6SD of 2–3 independent experiments.
doi:10.1371/journal.pone.0002369.g002
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c treated cells, the distribution of ZO-1 was very similar to
that in the control cells. The appearance of ZO-1 in the PhoP
c
group was similar to the control group when cells were viewed in
cross-Z-section (Figure 3. Z-section for Control and PhoP
c).
However, in cells treated with Salmonella derivative AvrA- mutant
(without AvrA), the normally smooth arc-like ZO-1 profiles were
transformed into a complex series of irregular undulations (Fig. 3
first row of panels AvrA2). Further, ZO-1 staining became
thinner and more sinuous. The Z-section panel in Fig. 3 shows the
weak staining of ZO-1 in AvrA2.
Claudin-1: Claudin-1 is highly enriched at sites of cell-cell
contact, co-localizing with the TJ marker, ZO-1 [29]. AvrA
absence induced a disorganization of transmembrane protein
claudin-1, and the protein was expanded intracellularly (Fig. 3
second row, see arrow). Interestingly, PhoP
C treatment also
slightly changed the distribution of claudin-1. Intracellular
Control PhoPc AvrA-
ZO-1
Claudin-1
 ZO-1
 Claudin-1
 DAPI
Z-
section
Figure 3. Immunostaining of claudin-1 and ZO-1 in cells colonized with AvrA-sufficient or -deficient bacteria in vitro. T84 monolayers
were treated with PhoPc or AvrA-. After 8 hours, the monolayers were fixed and immunostained for claudin-1 and ZO-1. ZO-1 distribution in the
control cells without any treatment has its normally smooth nature. In PhoP
c-treated cells, the distribution of ZO-1 was very similar to that in the
control cells. ZO-1’s appearance in PhoP
c group was similar as the control group when cells were viewed in cross-Z-section (Z-section for Control and
PhoP
c). However, in cells treated with Salmonella derivative AvrA- mutant (without AvrA), the normally smooth arc-like ZO-1 profiles were
transformed into a complex series of irregular undulations (first row of panels AvrA-). ZO-1 staining became thinner and more sinuous. The Z-section
panel in Fig. 3 shows the weak staining of ZO-1 in AvrA-. AvrA absence induced a disorganization of transmembrane protein claudin-1, and the
protein was moreover expanded intracellularly (second row, see arrow). PhoP
C treatment also slightly changed the distribution of claudin-1.
Intracellular claudin-1 was detectable in the cytosol of the cells colonized with PhoP
c. Results are representative of 5 independent experiments.
doi:10.1371/journal.pone.0002369.g003
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PhoP
c. This indicated that additional bacterial proteins may be
involved in regulating TJs. Overall, our immunofluorescence data
suggest that AvrA modulates junctional localization of ZO-1 and
claudin-1 proteins.
TER and AvrA expression
Transepithelial resistance (TER) is a measure of intestinal
epithelial integrity and tissue viability [30,31]. We assessed the
TER of the epithelial cells before and after bacterial colonization.
Cells were colonized with AvrA-sufficient or -deficient bacterial
strains for 30 minutes and then washed. TER of monolayers was
measured after switching to fresh media containing gentamicin to
prevent further bacterial growth. Our data showed that the
baseline TER (V cm
2) at 0 minute in controls without treatment
was 987.166.8 V cm
2. The TER values for cultured epithelial
cells from the control group remained relatively stable over the 30
to 90 minute incubation period. There was a decrease of TER
(482.165.3 V cm
2) after AvrA- colonization for 30 minutes,
whereas parental PhoP
c, a derivative of wild-type Salmonella
SL14028s, did not change TER significantly. It is consistent with
previous study that SL14028s did not have effect on the TER of
T84 cells [25]. In our study, the TER change was focus in the
initial 6 hours. Overall, cells colonized with the AvrA-deficient
bacterial strain (AvrA2) had the lowest TER compared to the
control, PhoP
c, and PhoPc AvrA+/ AvrA2 groups, but there was
no significant difference among the groups(data not shown).
AvrA expression and permeability in vivo
To assess the biological relevance of AvrA expression in vivo,w e
utilized a streptomycin-pretreatment mouse model [13] and
gavaged the mice with parental PhoP
c, AvrA-, or PhoP
c AvrA2/
AvrA+ strains. Immunofluorescence-tagged FITC-dextran was also
gavaged in each mouse for the permeability assay (Fig. 4). Mouse
serum was collectedto measure the intensity of fluorescence.Higher
FITC readings indicate higher permeability of the intestine. There
was a 5-fold increase of the fluorescence reading in the AvrA-
infected mouse serum compared to that in the PhoP
c mouse serum.
In the PhoP
c AvrA2/AvrA+ group, complemented AvrA expres-
sion was able to significantly decrease cell permeability. Our data
demonstrated that AvrA-sufficient bacteria significantly decrease
the intestinal permeability compared to AvrA-deficient bacteria. It
indicates the physiological function of AvrA in preserving intestinal
epithelial cell integrity in vivo.
AvrA expression stabilizes the expression of the tight
junction proteins in vivo
We collected the epithelial cells from mouse colon and
quantitated the TJ protein expression (Fig. 5). As expected, wild-
type Salmonella 14028s colonization decreased the total amount
ZO-1, claudin-1, and occludin-1 protein expression. AvrA-
decreased ZO-1, claudin-1, and occludin-1 expression, whereas
total occludin-1 expression was increased by the parental PhoP
c
strain with AvrA expression. Interestingly, the claudin-1 expres-
sion was stabilized but not increased by the PhoP
c colonization. In
the PhoP
c AvrA2/AvrA+ group with complemented AvrA, the
expression of ZO-1, claudin-1, and occludin-1 was stabilized to
levels comparable to those in the samples from the parental PhoP
c-
treated group. Compared to the normal mice without bacterial
infection, all the bacterial infected colonic epithelial cells had
decrease ZO-1 expression. In a cell cultured model, E.coli F18
infection failed to change the expression of TJ proteins (Fig. 1).
However, E.coli F18 infection in vivo decreased ZO-1 expression.
This suggests that other bacterial proteins are involved in the
regulation of ZO-1 expression in vivo. Interestingly, wild-type
Salmonella and E.coli F18 infection did not change the expression of
a-catenin in vivo. AvrA has no effect on the expression of a-catenin.
AvrA expression changes the distribution of tight
junction proteins in vivo
Immunostaining of ZO-1 and claudin-1 in the experimental
animal models further showed that parental PhoP
c with AvrA
expression maintained TJ structure in the epithelial cells.
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Figure 4. AvrA regulated permeability in the human colonic
epithelial cells. Permeability of the intestine in vivo. Data are
representative of three experiments. P,.05 for control vs. AvrA-, PhoP
C
vs. AvrA-, and AvrA- vs. AvrA2/+ after infection for 28 hours.
doi:10.1371/journal.pone.0002369.g004
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Figure 5. The Salmonella AvrA protein modulated ZO-1,
occludin, and claudin-1 expression in vivo. Mice were infected
with bacteria for 18 hrs and intestinal epithelial cells were harvested for
ZO-1, claudin-1, occludin, and a-catenin expression by immunoblot.
E x p e r i m e n t a lg r o u p s :C :n o r m a lm o u s ec e l l s ;W T :w i l d - t y p eS.
Typhimurium ATCC 14028s without sufficient AvrA protein expression;
PhoP
c: parental PhoP
c with sufficient AvrA protein expression; AvrA
2:
PhoP
c AvrA mutant; PhoP
c AvrA
2/AvrA
+: PhoP
c AvrA- transcomple-
mented with a plasmid encoding WT AvrA; or E.coli F18: commensal
bacteria isolated from human intestine. Images shown are from a single
experiment and are representative of three separate experiments.
doi:10.1371/journal.pone.0002369.g005
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enterocytes in both normal control and PhoP
c–treated animals.
Intracellular ZO-1 deposits were not detected after PhoP
c
infection. Under low magnitude observation in Fig. 6, we found
that the AvrA-deficient mutant disrupted the TJ structure, whereas
parental PhoP
c with AvrA protein expression stabilized the TJ
structure. Arrows in Fig. 6 ZO-1 show the red staining of ZO-1
protein on the top of the intestinal crypts. Please note the
disorganized structure of ZO-1 in the colonic epithelial cells
infected with the AvrA- bacterial strain. Under high magnification
observation in Fig. 7: the ring like structure of ZO-1 was disrupted
in mouse colon infected by the AvrA-deficient bacteria.
Claudin-1: The staining of green claudin-1 is weaker in the
AvrA- treated intestinal epithelium. Intracellular claudin-1
deposits were not detected after PhoP
c or AvrA- infection. These
in vivo data combined with in vitro data (Fig. 3) indicate that
additional bacterial proteins may be involved in regulating the
distribution of the TJ proteins. Overall, our immunofluorescent
data suggested that AvrA modulates junctional localization of ZO-
1 and claudin-1 proteins.
Also, in Fig. 6AvrA- with ZO-1, Claudin-1 overlapped DAPI
staining; there was increased inflammation in the epithelial cells as
measured by lymphoid aggregation, whereas the tight junction
structure was disrupted. Our H & E staining indicated that AvrA
absence in the bacterial strain (AvrA-) increased the inflammation
score in the infected intestine (data not shown). In the mice
infected with parental PhoP
c, the tight junction structure was still
well organized, and there was less inflammation in the intestine.
AvrA protein expression attenuates IL-6 secretion
It is known that cells colonized with AvrA-sufficient bacteria
lack inflammatory response [17]. AvrA may stabilize TJ structure
Figure 6. Immunostaining of claudin-1 and ZO-1 in vivo. Immunostaining on mouse colonic epithelial cells was performed 24 hours after
mouse infection with PhoP
c, AvrA
2 or AvrA
2/AvrA
+. Experimental groups: Control: normal mouse cells; PhoP
c: mice infected with parental PhoP
c with
sufficient AvrA protein expression; AvrA
2: mice infected with PhoP
c AvrA mutant. Tissues were fixed, permeabilized, and stained with claudin-1 and
ZO-1 antibodies, followed by A488 secondary antibodies, A594 secondary antibodies, and DAPI. AvrA
2 infected mice display disruption of the TJ
structure. Arrows in Panel ZO-1 show the red staining of ZO-1 protein on the top of the intestinal crypts. White arrow in Panel AvrA- DAPI shows
lymphoid aggregation. Please note disorganized structure of ZO-1 in the colonic epithelial cells infected with AvrA- bacterial strain. Images shown are
from a single experiment and are representative of three separate experiments. n=3 animals in each experimental group.
doi:10.1371/journal.pone.0002369.g006
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relevance of AvrA expression in vivo, we infected mice with WT
Salmonella Typhimurium strain 14028s (WT) with insufficient AvrA
expression or WT 14028s with AvrA overexpression (WTAvrA+).
As shown in Fig. 8A, AvrA protein expression is undetectable in
WT Salmonella14028s, whereas WTAvrA+ showed a significant
increase in AvrA expression. We measured the inflammatory
cytokine IL-6 in mouse serum after bacterial infection. WT
Salmonella induced significantly more IL-6 secretion as measured in
infected mouse serum than did the WTAvrA+ (Fig. 8B). In mice
infected with the WTAvrA+, AvrA overexpression was able to
lower IL-6 serum levels. It is suggested that AvrA expression in the
WT Salmonella is able to decrease the expression of inflammatory
cytokine IL-6.
Discussion
Our data demonstrate that the bacterial effector protein AvrA
stabilizes the expression and distribution of tight junction proteins
such as ZO-1, and the function of tight junctions in vitro and in vivo.
AvrA overexpression in transfected colonic epithelial cells
increases TJ protein expression. Bacterial strains with AvrA
stabilize host cell permeability, cell adhesion, and tight junction
and inhibit the inflammatory response. In contrast, AvrA-deficient
strains induce morphological and biochemical changes, including
increased cell permeability, disrupted TJ structure, and inflam-
matory responses.
An intriguing aspect of this study is the finding that AvrA stabilized
the TJs, whereas the other TTSS proteins, SopB, SopE, SopE2, and
SpiA, are known to disrupt the TJs [10]. Although initially this
observation appears unusual, it may represent a highly refined
bacterial strategy to overcome many effective host defense mecha-
nisms. Previous studies have demonstrated that AvrA does not
stimulate fluid secretion into infected calf ileal loops, whereas SopB
and SopD elevate fluid accumulation in bovine intestine [20].
Current studies show that lack of AvrA increases the cellpermeability
and disrupted TJ structure, whereas AvrA expression is able to
maintaintheTJstructureandfunctionandlimitthecellpermeability.
Figure 7. Higher magnification of claudin-1 and ZO-1 immunostaining in vivo. Arrows in Panel ZO-1 show red staining of ZO-1 protein on
the top of the intestinal crypts. Panel AvrA
2 showing disrupted ZO-1 and weaker claudin-1 staining in epithelial cells. ZO1 was detected at the tight
junction of villous enterocytes in both normal control and PhoP
c–treated animals. No intracellular ZO-1 deposits were detected after PhoP
c infection.
The ring-like structure of ZO-1 was disrupted in mouse colon infected by the AvrA-deficient bacteria. The staining of claudin-1 is weaker in the AvrA-
treated intestinal epithelium. No intracellular claudin-1 deposits were detected after PhoP
c or AvrA- infection. n=3 animals in each experimental
group.
doi:10.1371/journal.pone.0002369.g007
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suggest a different role for AvrA distinct from the role of other
Salmonella effectors in regulating fluid accumulation in intestine.
Salmonella effectors, such as SopB, SopE, SopE2, are know to
activate the proinflammatory response by directly stimulating
proinflammatory signaling events in host cells [32,33,34,35]. In
contrast, AvrA is able to attenuate the key proinflammatory NF-
kB transcription factor [14,17], activate the b-catenin transcrip-
tion factor [27,36], and inhibit cell apoptosis in mouse epithelial
cells [17]. Therefore, AvrA may function as an anti-inflammatory
protein to stabilize TJs, prevent cell death, and help the bacteria
survive in the host; whereas the other bacterial effectors do the
opposite. Further investigation is needed to determine whether
AvrA influences TJ by damping the inflammatory response in the
host epithelial cells. Characterization of the synergistic functions of
AvrA with other bacterial effectors and toxins will give new clues
concerning microbial–host interaction in inflammation.
The PhoP
c we used is a derivative of wild-type Salmonella
Typhimurium SL14028. Previous studies indicated that infection
with wild type SL14028 did not influence TER [25], whereas
recent studies using the SL1344 showed different results [10,26].
Several factors explain these differences. First, the S. Typhimur-
ium background of these strains is different. Since the SL1344
strain induces a more robust response in the ability to induce PMN
transepithelial migration than the 14028 strain, and this
differences in the virulence phenotype could explain, in part,
differences at the level of the TER [26]. Second, the level of AvrA
expression by a particular Salmonella strain may ultimately
determine how that organism will behave. Wild type Salmonella
strains express AvrA conditionally, but at levels insufficient to
counteract the actions of other bacterial agents. SL14028 does not
have detectable AvrA protein [18,19], whereas the SL1344
sufficiently expresses AvrA protein [11]. Therefore, the TER
was not changed by infection with SL14028, whereas it was
changed by infection with SL1344.
We have found that expression of occludin-1, claudin-1, and
ZO-1 are altered by AvrA expression using a gene-transfected
system, cultured polarized epithelial cells, and a mouse model.
Based on our data, AvrA likely has a specific role in the expression
of ZO-1 and occludin. The key 186 amino acid cysteine is
required for AvrA regulation of TJ expression. However, it is not
clear whether AvrA regulates these TJ proteins through phos-
phorylation or through ubiquitination. AvrA acts as a deubiqui-
tinase to inhibit the degradation of the inflammatory regulators
IkBa and b-catenin [17]. Occludin is a functional target of the E3
ligase Itch [37]. Thus, AvrA may stabilize TJ protein by removing
ubiquitin from occludin. Rho GTPase is known to be involved in
bacteria-induced tight junction disruption [10,38,39,40,41]. Our
current study demonstrates that AvrA is able to stabilize the TJ
structure, but it is unclear whether Rho GTPase is influenced by
the AvrA expression. Future studies will explore these questions
and provide further insight into bacteria-host interactions during
inflammation. Taken together, our data and the findings of others
indicate that bacteria, in order to survive in the host, have evolved
multiple approaches of hijacking host epithelial cells.
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